The phosphoenolpyruvate phosphotransferase system in group A Streptococcus acts to reduce streptolysin s activity and lesion severity during soft tissue infection

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 1192-1204

  Gera, Kanika ^a   Le, Tuquynh ^a   Jamin, Rebecca ^b   Eichenbaum, Zehava ^b   McIver, Kevin S ^a  

^a University of Maryland   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BACTERIAL PROTEINS; CARBOHYDRATES; EXOTOXINS; FEMALE; GENES, BACTERIAL; MICE; MUTATION; PHOSPHOENOLPYRUVATE SUGAR PHOSPHOTRANSFERASE SYSTEM; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE; VIRULENCE FACTORS;

EID: 84894239183     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01271-13     Document Type: Article

References (60)

1. Deutscher J, Francke C, Postma PW. 2006. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 70:939-1031. http://dx.doi.org /10.1128/MMBR.00024-06.
2. Gorke B, Stulke J. 2008. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat. Rev. Microbiol. 6:613-624. http://dx.doi.org/10.1038/nrmicro1932.
3. Hondorp ER, Hou SC, Hause LL, Gera K, Lee CE, McIver KS. 2013. PTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus. Mol. Microbiol. 88:1176-1193. http://dx.doi .org/10.1111/mmi.12250.
4. Cho KH, Caparon MG. 2005. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol. Microbiol. 57:1545-1556. http://dx.doi.org/10.1111/j.1365-2958.2005.04786.x.
5. Munoz-Elias EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644. http://dx.doi.org/10.1038/nm1252.
6. Rollenhagen C, Bumann D. 2006. Salmonella enterica highly expressed genes are disease specific. Infect. Immun. 74:1649-1660. http://dx.doi.org /10.1128/IAI.74.3.1649-1660.2006.
7. Iyer R, Camilli A. 2007. Sucrose metabolism contributes to in vivo fitness of Streptococcus pneumoniae. Mol. Microbiol. 66:1-13. http://dx.doi.org /10.1111/j.1365-2958.2007.05878.x.
8. Son MS, Matthews WJ, Jr, Kang Y, Nguyen DT, Hoang TT. 2007. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75:5313-5324. http://dx.doi.org/10.1128/IAI.01807-06.
9. Lengeler JW, Jahreis K. 2009. Bacterial PEP-dependent carbohydrate: phosphotransferase systems couple sensing and global control mechanisms. Contrib. Microbiol. 16:65-87. http://dx.doi.org/10.1159 /000219373.
10. Postma PW, Lengeler JW, Jacobson GR. 1993. Phosphoenolpyruvate: carbohydrate phosphotransferase systems of bacteria. Microbiol. Rev. 57: 543-594.
11. Kruger S, Gertz S, Hecker M. 1996. Transcriptional analysis of bglPH expression in Bacillus subtilis: evidence for two distinct pathways mediating carbon catabolite repression. J. Bacteriol. 178:2637-2644.
12. McAllister LJ, Ogunniyi AD, Stroeher UH, Paton JC. 2012. Contribution of a genomic accessory region encoding a putative cellobiose phosphotransferase system to virulence of Streptococcus pneumoniae. PLoS One 7:e32385. http://dx.doi.org/10.1371/journal.pone.0032385.
13. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79:882-899. http://dx.doi.org/10.1111/j.1365-2958.2010.07495.x.
14. Stoll R, Mertins S, Joseph B, Muller-Altrock S, Goebel W. 2008. Modulation of PrfA activity in Listeria monocytogenes upon growth in different culture media. Microbiology 154:3856-3876. http://dx.doi.org/10.1099 /mic.0.2008/018283-0.
15. Tsvetanova B, Wilson AC, Bongiorni C, Chiang C, Hoch JA, Perego M.2007. Opposing effects of histidine phosphorylation regulate the AtxA virulence transcription factor in Bacillus anthracis. Mol. Microbiol. 63: 644-655.
16. Fujita Y. 2009. Carbon catabolite control of the metabolic network in Bacillus subtilis. Biosci. Biotechnol. Biochem. 73:245-259. http://dx.doi .org/10.1271/bbb.80479.
17. Iyer R, Baliga NS, Camilli A. 2005. Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J. Bacteriol. 187:8340-8349. http://dx.doi.org/10.1128 /JB.187.24.8340-8349.2005.
18. Kietzman CC, Caparon MG. 2010. CcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes. Infect. Immun. 78: 241-252. http://dx.doi.org/10.1128/IAI.00746-09.
19. Kinkel TL, McIver KS. 2008. CcpA-mediated repression of streptolysin S expression and virulence in the group A streptococcus. Infect. Immun. 76:3451-3463. http://dx.doi.org/10.1128/IAI.00343-08.
20. Seidl K, Stucki M, Ruegg M, Goerke C, Wolz C, Harris L, Berger-Bachi B, Bischoff M. 2006. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob. Agents Chemother. 50:1183-1194. http://dx.doi.org/10.1128/AAC.50.4.1183-1194 .2006.
21. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen groupA Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698-1703. http://dx.doi .org/10.1073/pnas.0711767105.
22. Varga J, Stirewalt VL, Melville SB. 2004. The CcpA protein is necessary for efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens. J. Bacteriol. 186:5221-5229. http://dx.doi.org/10.1128/JB .186.16.5221-5229.2004.
23. Zeng L, Burne RA. 2010. Seryl-phosphorylated HPr regulates CcpAindependent carbon catabolite repression in conjunction with PTS permeases in Streptococcus mutans. Mol. Microbiol. 75:1145-1158. http://dx .doi.org/10.1111/j.1365-2958.2009.07029.x.
24. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. J. Gen. Microbiol. 129:643-651. http://dx.doi.org/10.1099/00221287-129-3-643.
25. Dassy B, Alouf JE. 1983. Growth of Streptococcus pyogenes and streptolysin O production in complex and synthetic media. J. Gen. Microbiol. 129:643-651. http://dx.doi.org/10.1099/00221287-129-3-643.
26. Pine L, Reeves MW. 1978. Regulation of the synthesis of M protein by sugars, Todd Hewitt broth, and horse serum, in growing cells of Streptococcus pyogenes. Microbios 21:185-212.
27. Musser JM, Shelburne SA, III. 2009. A decade of molecular pathogenomic analysis of group A Streptococcus. J. Clin. Invest. 119:2455-2463. http://dx.doi.org/10.1172/JCI38095.
28. Loughman JA, Caparon MG. 2006. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes.EMBOJ. 25:5414-5422. http://dx .doi.org/10.1038/sj.emboj.7601393.
29. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771-782. http://dx.doi.org/10.1086 /432514.
30. Podbielski A, Woischnik M, Kreikemeyer B, Bettenbrock K, Buttaro BA. 1999. Cysteine protease SpeB expression in group A streptococci is influenced by the nutritional environment but SpeB does not contribute to obtaining essential nutrients. Med. Microbiol. Immunol. 188:99-109. http://dx.doi.org/10.1007/s004300050111.
31. van de Rijn I, Kessler RE. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27: 444-448.
32. Horton RM. 1995. PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Mol. Biotechnol. 3:93-99.
33. Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, Liu M, Dou SJ, Adams GG, Musser JM. 2000. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect. Immun. 68:535-542. http://dx.doi.org/10.1128/IAI.68.2.535-542 .2000.
34. Engleberg NC, Heath A, Vardaman K, DiRita VJ. 2004. Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect. Immun. 72:623-628. http://dx.doi.org/10.1128/IAI.72.2.623-628.2004.
35. Lukomski S, Montgomery CA, Rurangirwa J, Geske RS, Barrish JP, Adams GJ, Musser JM. 1999. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67:1779-1788.
36. Connolly KL, Roberts AL, Holder RC, Reid SD. 2011. Dispersal of group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLoS One 6:e18984. http://dx.doi.org /10.1371/journal.pone.0018984.
37. Doern CD, Roberts AL, Hong W, Nelson J, Lukomski S, Swords WE, Reid SD. 2009. Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiology 155:46-52. http://dx.doi.org/10.1099/mic.0 .021048-0.
38. Roberts AL, Holder RC, Reid SD. 2010. Allelic replacement of the streptococcal cysteine protease SpeB in a Δsrv mutant background restores biofilm formation.BMCRes. Notes 3:281. http://dx.doi.org/10.1186/1756-0500-3-281.
39. Fontaine MC, Lee JJ, Kehoe MA. 2003. Combined contributions of streptolysinOand streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect. Immun. 71:3857-3865. http://dx.doi .org/10.1128/IAI.71.7.3857-3865.2003.
40. Heath A, DiRita VJ, Barg NL, Engleberg NC. 1999. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect. Immun. 67:5298-5305.
41. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, De Azavedo JC.2000. Genetic locus for streptolysin S production by group A streptococcus. Infect. Immun. 68:4245-4254. http://dx.doi.org/10.1128/IAI.68.7 .4245-4254.2000.
42. Vadeboncoeur C, Frenette M, Lortie LA. 2000. Regulation of the pts operon in low G+C Gram-positive bacteria. J. Mol. Microbiol. Biotechnol. 2:483-490.
43. Song JH, Ko KS, Lee JY, Baek JY, Oh WS, Yoon HS, Jeong JY, Chun J.2005. Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis. Mol. Cells 19:365-374.
44. Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto RT, Xu H, Trawick JD, Wall D, Wang L, Brown-Driver V, Froelich JM, Kedar GC, King P, McCarthy M, Malone C, Misiner B, Robbins D, Tan Z, Zhu ZY, Carr G, Mosca DA, Zamudio C, Foulkes JG, Zyskind JW. 2002. A genomewide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol. 43:1387-1400. http://dx.doi.org/10.1046/j.1365-2958.2002.02832.x.
45. Chaudhuri RR, Allen AG, Owen PJ, Shalom G, Stone K, Harrison M, Burgis TA, Lockyer M, Garcia-Lara J, Foster SJ, Pleasance SJ, Peters SE, Maskell DJ, Charles IG. 2009. Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics 10:291. http://dx.doi.org/10.1186 /1471-2164-10-291.
46. Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, Maruf M, Hutchison CA, III, Smith HO, Venter JC. 2006. Essential genes of a minimal bacterium. Proc. Natl. Acad. Sci. U. S. A. 103:425-430. http://dx .doi.org/10.1073/pnas.0510013103.
47. French CT, Lao P, Loraine AE, Matthews BT, Yu H, Dybvig K. 2008. Large-scale transposon mutagenesis of Mycoplasma pulmonis. Mol. Microbiol. 69:67-76. http://dx.doi.org/10.1111/j.1365-2958.2008.06262.x.
48. Siemens N, Fiedler T, Normann J, Klein J, Munch R, Patenge N, Kreikemeyer B. 2012. Effects of the ERES pathogenicity region regulator Ralp3 on Streptococcus pyogenes serotype M49 virulence factor expression. J. Bacteriol. 194:3618-3626. http://dx.doi.org/10.1128/JB.00227-12.
49. Shelburne SA, III, Keith DB, Davenport MT, Horstmann N, Brennan RG, Musser JM. 2008. Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol. Microbiol. 69:436-452. http://dx.doi.org/10.1111/j.1365-2958.2008.06290.x.
50. Shelburne SA, Fang H, Okorafor N, Sumby P, Stikiewicz I, Keith D, Patel P, Austin C, Graviss EA, Musser JM, Chow D. 2007. MalE of group A Streptococcus participates in the rapid transport of maltotriose and longer maltodextrins. J. Bacteriol. 189:2610-2617. http://dx.doi.org/10.1128 /JB.01539-06.
51. Bidossi A, Mulas L, Decorosi F, Colomba L, Ricci S, Pozzi G, Deutscher J, Viti C, Oggioni MR. 2012. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. PLoS One 7:e33320. http://dx.doi.org/10.1371/journal.pone.0033320.
52. Darbon E, Servant P, Poncet S, Deutscher J. 2002. Antitermination by GlpP, catabolite repression via CcpA and inducer exclusion triggered by P-GlpK dephosphorylation control Bacillus subtilis glpFK expression. Mol. Microbiol. 43:1039-1052. http://dx.doi.org/10.1046/j.1365-2958 .2002.02800.x.
53. Kok M, Bron G, Erni B, Mukhija S. 2003. Effect of enzyme I of the bacterial phosphoenolpyruvate: sugar phosphotransferase system (PTS) on virulence in a murine model. Microbiology 149:2645-2652. http://dx .doi.org/10.1099/mic.0.26406-0.
54. Molloy EM, Cotter PD, Hill C, Mitchell DA, Ross RP. 2011. Streptolysin S-like virulence factors: the continuing sagA. Nat. Rev. Microbiol. 9:670-681. http://dx.doi.org/10.1038/nrmicro2624.
55. Gao J, Gusa AA, Scott JR, Churchward G. 2005. Binding of the global response regulator protein CovR to the sag promoter of Streptococcus pyogenes reveals a new mode of CovR-DNA interaction. J. Biol. Chem. 280: 38948-38956. http://dx.doi.org/10.1074/jbc.M506121200.
56. Hanahan D, Meselson M. 1983. Plasmid screening at high colony density. Methods Enzymol. 100:333-342.
57. Miroux B, Walker JE. 1996. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 290:289-298. http://dx.doi .org/10.1006/jmbi.1996.0399.
58. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE, Nizet V, Kotb M. 2004. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol. 51:123-134.
59. Le Breton Y, Mistry P, Valdes KM, Quigley J, Kumar N, Tettelin H, McIver KS. 2013. Genome-wide identification of genes required for fitness of group A Streptococcus in human blood. Infect. Immun. 81:862-875. http://dx.doi.org/10.1128/IAI.00837-12.
60. Ribardo DA, McIver KS. 2006. Defining the Mga regulon: comparative transcriptome analysis reveals both direct and indirect regulation by Mga in the group A streptococcus. Mol. Microbiol. 62:491-508. http://dx.doi .org/10.1111/j.1365-2958.2006.05381.x.